Jinling Pharmaceutical (000919.SZ) reduced investment in securities and strove to develop medical service industry

   Date:2011-11-25xujintao
During Jan. to Sept. 2011, performance of Jiling Pharmaceutical steadily improved. Its operating revenue reached RMB1.67 billion, up 3.9% YoY; while its net income achieved RMB160 million, a rise o...
2005-2011 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1